dka pathphysiologymanagement2014-copy-140202235658-phpapp02
DESCRIPTION
so nice ppt fo DKA managementTRANSCRIPT
DIABETIC KETOACIDOSISIN ICU
PRESENTED BY:
DR. ZEENAT YASMEEN ICU RESIDENT
Diabetic Ketoacidosis (DKA)
• A state of absolute or relative insulin deficiency aggravated and followed by
• hyperglycemia, dehydration, and acidosis-producing derangements in metabolism, including production of serum acetone.
• Can occur in both Type I Diabetes and Type II Diabetes In type II diabetics with insulin deficiency/dependence
• It is the presenting symptom for ~ 25% of Type I Diabetics.
Hyperglycemia
Ketosis
Acidosis
*
Definition of Diabetic Ketoacidosis*
3
Pathogenesis of DKA
InsulinDeficiency
Beta-cellfailure
D/CInsulin
Glucotoxicity
Insulindeficiency
IncreasedglucagonGHcortisolcatecholamines
Pathogenesis of DKA
Carbohydrate Metabolism in DKA
Relative or absolute insulin deficiency
glucose output
glycogenolysis
liver
glucose uptake
muscle
Increased Glucose Production in DKA
Gluconeogenesis Glucose
Protein breakdownLipolysis
Glycerol Amino acids Lactate
TG
Activity of gluconeogenicenzymes (PEPCK, PC, PFK)
Increased Production of Ketones in DKA
Lipolysis
FFA Glycerol
Ketogenesis
B-OH-BAcetoacetate
TG
Pathogenesis of DKA
Liver
Increasedglucose
production
Decreasedglucoseuptake
Peripheraltissue
HYPERGLYCEMIA
Increasedrelease
FFA
Increasedketogenesis
Adiposetissue
Liver
KETOACIDOSIS
Osmotic diuresis
Volume depletion Metabolic acidosis
Decreased alkali reserve
Diagnostic Criteria for DKA
DKA
Mild Moderate Severe
Plasma glucose (mg/dl)pHAnion gap Bicarbonate (mEq/l)Urine ketones*Serum ketones*Effective serum Osmol (mOsm/kg)†Alteration in sensoriaor mental obtundation
>2507.25-7.3 >10 15-18positivepositivevariable
alert
>2507.0-<7.24 >1210- <15positivepositivevariable
alert/drowsy
>250<7.0 >12<10positivepositivevariable
stupor/coma
Clinical Presentation of DKA
SignHypothermiaTachycardiaTachypneaKussmaul
breathingIleusAcetone breathAltered sensorium
SymptomsPolydipsiaPolyuriaWeaknessWeight lossNausea Vomiting Abdominal pain
The onset of DKA is usually relative short, ranging from hours to a day or two.
Causes of DKA
• Stressful precipitating event that results in increased catecholamines, cortisol, glucagon. Infection (pneumonia, UTI) Alcohol Stroke Myocardial Infarction Pancreatitis Trauma Medications (steroids) Non-compliance with insulin
Initial Clinical Evaluation
• History and physical examination Secure patient’s ABC Mental status Cardiovascular-renal status Source of infection
• Evaluation of volume and hydration status
• Laboratory studies
• Immediate determination of blood glucose by finger stick, and serum ketones (3-BH) by finger stick or urinary ketones.
• Laboratory studies: ABG’s CBC with differential CMP (glucose, electrolytes, bicarbonate, BUN, creatinine) Serum ketones Urinalysis Bacterial cultures* Cardiac enzymes*
Initial Laboratory Studies
* If clinically indicated
Serum Sodium
Hyponatremia is common in patients with DKA
H2O
H2OH2O
Serum glucose
Na+
H2O
Correction of Serum sodium:
Corrected Na+ = [Na+] 1.6 x glucose (mg/dl) – 100
100
Serum Potassium
Admission serum potassium is frequently elevated (due to a shift of K- from the intracellular to the extracellular space)
K+
OsmolalityAcidosis
K+
Insulinregulates Activity
ofNa+/K+ pump
Na+
K-
K+
K+K+
Anion Gap Formula
• Anion gap can be measured as
• AG=[(Na)-(Hco3+CL)]
Fluid Therapy in DKA
Normal saline, 1-2 L over 1-2 h
NS or ½ NS at 250-500 mL/h
Glucose < 250 mg/dl
D5%1/2NS saline
Caution during fluid management
• Fluid should be replace over 12-24hr • patients are generally depleted 3-6lit in
DKA.• Monitor urine output,heart rate,blood
pressure and respiratory status.• CARE must b taken in patient with CCF
and kidney disease.
Blood Glucose monitoring in DKA• Check initial blood glucose q1h.Goal decrease in
blood glucose is 50-75mg/dl/hr• Once stable(3consecutie values decrease in
target range)change blood glucose monitoringq2h.Resume q1h blood glucose monitoring for each change in the insulin infusion rate.
• Add dextrose5% to IV fluid when blood glucose <250mg/dl.
• For DKA goal blood glucose 150-200mg/dl until anion gap close.
Intravenous Insulin Therapy in DKA
I.V. Bolus: 0.1 U/kg
I.V. drip: 0.1 U/kg/h
Glucose < 250 mg/dl and HCO3 > 15 mmol/l, then,
I.V. drip: 0.05 – 0.1 U/kg/h Until c0rrection of anion gap
CHANGING THE INSULIN INFUSION RATE
• Decrease IV insulin by 50%if blood glucose decrease by >100mg/dl/hr in any 1hr period
• Increase insulin drip by 50%/hr if change in blood glucose is <50mg/dl/hr
• When blood glucose decrease to 250mg/dl insulin infusion may need to be decrease 50% to maintain glucose at target levels(150-200mg/dl).
Transition to Subcutaneous Insulin
Patients with DKA should be treated with IV insulin until ketoacidosis is resolved.
Criteria for resolution of DKACriteria for resolution of DKA:: BG BG ≤≤ 200 mg/dL 200 mg/dL Serum bicarbonate level ≥ 18 mEq/LSerum bicarbonate level ≥ 18 mEq/L Venous pH ≥ 7.3 and anion gap closedVenous pH ≥ 7.3 and anion gap closed
WHEN TO STOP IV INSULIN
• Give short acting insulin SC at twice the hourly IV rate(if iv rate 5u/hr give 10u)
• Failure to give SC insulin may result in rebound hyperglycemia and ketosis due to its short acting effect.
• ENSURE pt has a meal and is eating and awake.
Potassium replacement
K+ = > 5.5 mEq/l; no supplemental is required
K+ = 4 - 5 mEq/l; 20 mEq/L of replacement fluid
K+ = 3 - 4 mEq/l; 40 mEq/L of replacement fluid
If admission K+ = <3 mEq/l give 10-20 mEq/h until K+ >3 mEq/l, then add 40 mEq/L to replacement fluid
pH > 7.0 no bicarbonate
pH < 7.0 and bicarbonate < 5 mEq/l 44.6 mEq in 500 ml 0.45% saline over 1 h until pH > 7.0
Bicarbonate administration
Complications of DKA 1-Complications of associated illnesses e.g.
sepsis or MI.2-Adult respiratory distress syndrome. 3-Thromboembolism (elderly). 4-Complications of treatment:
a-Hypokalemia: Which may lead to:
-Cardiac arrhythmias.
-Cardiac arrest.
-Respiratory muscle weakness.
b-Hypoglycemia.
c-Overhydration and acute pulmonary edema: particularly in:
-Treating children with DKA.
-Adults with compromised renal or cardiac function.
-Elderly with incipient CHF.
d-Neurological complications: Cerebral Edema.
-It occurs mostly in children with DKA.
-Very dangerous and increases mortality.
-The risk is related to the severity, duration and rapid correction of DKA.
Mechanism: The brain adapts by producing
intracellular osmoles (idiogenic osmoles) which stabilize the brain cells from shrinking while the DKA was developing. When the hyperosmolarity is rapidly corrected, the brain becomes hypertonic towards the extracellular fluids water flows into the cells cerebral edema
Diabetic Ketoacidosis is a common, serious and expensive complication in patients with type 1 and type 2 diabetes
Prevention of metabolic decompensation through patient education, strict surveillance of glucose homeostasis and aggressive diabetes management might reduce the high morbidity and mortality associated with diabetic ketoacidosis
Summary
THANK YOU